- Navigation
- Register My DNA Kit
- Features
- Pricing
- FAQ
- About
- Labs
- Login
- Get started
Interaction | References |
---|---|
BMS 754807 promotes the reaction [palbociclib results in decreased phosphorylation of RB1 protein] | R |
Interaction | References |
---|---|
CDKN2A gene modified form affects the susceptibility to palbociclib | R |
Interaction | References |
---|---|
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [palbociclib results in decreased expression of RBL1 protein] | R |
Interaction | References |
---|---|
palbociclib inhibits the reaction [[CDK6 protein binds to CCND3 protein] which results in increased phosphorylation of MEF2D protein] | R |
Interaction | References |
---|---|
[BMS 754807 co-treated with palbociclib] results in increased expression of CCND1 protein | R |
Interaction | References |
---|---|
palbociclib inhibits the reaction [Camptothecin results in increased activity of CASP3 protein] | R |
Interaction | References |
---|---|
CDK4 protein results in decreased susceptibility to palbociclib | R |
Interaction | References |
---|---|
palbociclib inhibits the reaction [[CDK6 protein binds to CCND3 protein] which results in increased phosphorylation of MEF2D protein] | R |
Interaction | References |
---|---|
Doxorubicin inhibits the reaction [palbociclib results in decreased phosphorylation of H2AFX protein] | R |
Interaction | References |
---|---|
palbociclib inhibits the reaction [Camptothecin results in increased activity of CASP7 protein] | R |